In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift.
Glioblastoma is the most common adult primary brain tumor and has a dismal median survival. Radiation is a mainstay of treatment and significantly improves survival, yet recurrence is nearly inevitable. Better understanding the radiation response of glioblastoma will help improve strategies to treat this devastating disease. Here, we present a comprehensive study of the in vivo radiation response of glioma cells in a mouse model of proneural glioblastoma. These tumors are a heterogeneous mix of cell types with differing radiation sensitivities. To explicitly study the gene expression changes comprising the radiation response of the Olig2(+) tumor bulk cells, we used translating ribosome affinity purification (TRAP) from Olig2-TRAP transgenic mice. Comparing both ribosome-associated and total pools of mRNA isolated from Olig2(+) cells indicated that the in vivo gene expression response to radiation occurs primarily at the total transcript level. Genes related to apoptosis and cell growth were significantly altered. p53 and E2F were implicated as major regulators of the radiation response, with p53 activity needed for the largest gene expression changes after radiation. Additionally, radiation induced a marked shift away from a proneural expression pattern toward a mesenchymal one. This shift occurs in Olig2(+) cells within hours and in multiple genetic backgrounds. Targets for Stat3 and CEBPB, which have been suggested to be master regulators of a mesenchymal shift, were also up-regulated by radiation. These data provide a systematic description of the events following radiation and may be of use in identifying biological processes that promote glioma radioresistance.
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
John
J
Halliday
Karim
K
Helmy
Siobhan S
SS
Pattwell
Kenneth L
KL
Pitter
Quincey
Q
LaPlant
Tatsuya
T
Ozawa
Eric C
EC
Holland
D000818:Animals; D000831:Animals, Newborn; D001932:Brain Neoplasms / Q000473:pathology*; D050684:E2F Transcription Factors / Q000502:physiology; D005909:Glioblastoma / Q000473:pathology*; D008648:Mesoderm / Q000166:cytology / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D011836:Radiation Tolerance / Q000235:genetics*; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology*
D050684:E2F Transcription Factors; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53